Literature DB >> 26424644

Chromatin Structure of Epstein-Barr Virus Latent Episomes.

Paul M Lieberman1.   

Abstract

EBV latent infection is characterized by a highly restricted pattern of viral gene expression. EBV can establish latent infections in multiple different tissue types with remarkable variation and plasticity in viral transcription and replication. During latency, the viral genome persists as a multi-copy episome, a non-integrated-closed circular DNA with nucleosome structure similar to cellular chromosomes. Chromatin assembly and histone modifications contribute to the regulation of viral gene expression, DNA replication, and episome persistence during latency. This review focuses on how EBV latency is regulated by chromatin and its associated processes.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26424644     DOI: 10.1007/978-3-319-22822-8_5

Source DB:  PubMed          Journal:  Curr Top Microbiol Immunol        ISSN: 0070-217X            Impact factor:   4.291


  21 in total

1.  Epstein-Barr Virus BKRF4 Gene Product Is Required for Efficient Progeny Production.

Authors:  H M Abdullah Al Masud; Takahiro Watanabe; Masahiro Yoshida; Yoshitaka Sato; Fumi Goshima; Hiroshi Kimura; Takayuki Murata
Journal:  J Virol       Date:  2017-11-14       Impact factor: 5.103

2.  Structural Basis for Cooperative Binding of EBNA1 to the Epstein-Barr Virus Dyad Symmetry Minimal Origin of Replication.

Authors:  Kimberly A Malecka; Jayaraju Dheekollu; Julianna S Deakyne; Andreas Wiedmer; Ursula D Ramirez; Paul M Lieberman; Troy E Messick
Journal:  J Virol       Date:  2019-09-30       Impact factor: 5.103

3.  Identification of ARKL1 as a Negative Regulator of Epstein-Barr Virus Reactivation.

Authors:  Umama Z Siddiqi; Anup S Vaidya; Xinliu Li; Edyta Marcon; Sai Wah Tsao; Jack Greenblatt; Lori Frappier
Journal:  J Virol       Date:  2019-09-30       Impact factor: 5.103

4.  Epstein-Barr Virus Oncoprotein LMP1 Mediates Epigenetic Changes in Host Gene Expression through PARP1.

Authors:  Kayla A Martin; Lena N Lupey; Italo Tempera
Journal:  J Virol       Date:  2016-09-12       Impact factor: 5.103

Review 5.  Interplay between Epstein-Barr virus infection and environmental xenobiotic exposure in cancer.

Authors:  Francisco Aguayo; Enrique Boccardo; Alejandro Corvalán; Gloria M Calaf; Rancés Blanco
Journal:  Infect Agent Cancer       Date:  2021-06-30       Impact factor: 2.965

Review 6.  Transcriptional and Epigenetic Regulatory Mechanisms Affecting HTLV-1 Provirus.

Authors:  Paola Miyazato; Misaki Matsuo; Hiroo Katsuya; Yorifumi Satou
Journal:  Viruses       Date:  2016-06-16       Impact factor: 5.048

7.  Structural basis underlying viral hijacking of a histone chaperone complex.

Authors:  Hongda Huang; Zhong Deng; Olga Vladimirova; Andreas Wiedmer; Fang Lu; Paul M Lieberman; Dinshaw J Patel
Journal:  Nat Commun       Date:  2016-09-01       Impact factor: 14.919

Review 8.  The conundrum of the Epstein-Barr virus-associated gastric carcinoma in the Americas.

Authors:  Gonzalo Carrasco-Avino; Ismael Riquelme; Oslando Padilla; Miguel Villaseca; Francisco R Aguayo; Alejandro H Corvalan
Journal:  Oncotarget       Date:  2017-06-15

9.  Carcinoma-risk variant of EBNA1 deregulates Epstein-Barr Virus episomal latency.

Authors:  Jayaraju Dheekollu; Kimberly Malecka; Andreas Wiedmer; Henri-Jacques Delecluse; Alan K S Chiang; Dario C Altieri; Troy E Messick; Paul M Lieberman
Journal:  Oncotarget       Date:  2017-01-31

Review 10.  Exosomes in Nasopharyngeal Carcinoma.

Authors:  Yujuan Zhou; Longzheng Xia; Jingguan Lin; Heran Wang; Linda Oyang; Shiming Tan; Yutong Tian; Min Su; Hui Wang; Deliang Cao; Qianjin Liao
Journal:  J Cancer       Date:  2018-02-11       Impact factor: 4.207

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.